Works matching IS 19705557 AND DT 2021 AND VI 15 AND IP 2
Results: 5
Donafenib in Chinese patients with advanced hepatocellular carcinoma (HCC): Really a new standard of care, or should we change paradigm for drug development in HCC?
- Published in:
- Oncology Reviews, 2021, v. 15, n. 2, p. 36, doi. 10.4081/oncol.2021.564
- By:
- Publication type:
- Article
The effect of imatinib and nilotinib on blood calcium and blood potassium levels in chronic myeloid leukemia patients: a literature review.
- Published in:
- Oncology Reviews, 2021, v. 15, n. 2, p. 26, doi. 10.4081/oncol.2021.547
- By:
- Publication type:
- Article
Molecular insights and clinical impacts of extracellular vesicles in cancer.
- Published in:
- Oncology Reviews, 2021, v. 15, n. 2, p. 17, doi. 10.4081/oncol.2021.542
- By:
- Publication type:
- Article
Programmed death ligand-1 protein expression difference in basal like and non-basal like triple negative breast cancer and its association with disease free survival and overall survival: A systematic review.
- Published in:
- Oncology Reviews, 2021, v. 15, n. 2, p. 10, doi. 10.4081/oncol.2021.533
- By:
- Publication type:
- Article
Immunotherapy using PD-1/PDL-1 inhibitors in metastatic triple-negative breast cancer: A systematic review.
- Published in:
- Oncology Reviews, 2021, v. 15, n. 2, p. 1, doi. 10.4081/oncol.2021.497
- By:
- Publication type:
- Article